OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Philip Van Damme

1 Projects | 1 Researchers | $130,000 Invested

2009

VIB

Philip Van Damme, MD, PhD

Drug Discovery for Progranulin-Mediated Frontotemporal Lobar Degeneration

  • Funding Amount: $130,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed